Biochemistry, Genetics and Molecular Biology
Nested Gene
100%
MicroRNA
50%
Association
48%
Gene Expression
47%
Pharmacogenomics
46%
Single-Nucleotide Polymorphism
46%
Genetic Divergence
45%
Phenotype
40%
Haplotype Map
36%
Drug Response
35%
Single Nucleotide Polymorphism
35%
Genetics
33%
Cytotoxicity
33%
Mutation
30%
Cancer Cell
27%
Sample
26%
microRNA
26%
Drug Sensitivity
24%
Transcriptome
22%
Protein
21%
Cisplatin
20%
Germline
19%
Electric Potential
19%
Coding
19%
Pharmacogenetics
18%
Genome-Wide Association Study
18%
Genotyping
18%
Cell Growth
15%
Expression Quantitative Trait Loci
15%
Long Noncoding RNA
13%
Messenger RNA
13%
Case-Control Study
12%
Genetic Determinism
12%
Capecitabine
12%
Clinical Trial
10%
Tumor Gene
10%
Allele
9%
Gene Expression Level
9%
Development
9%
Human
9%
Cell Proliferation
8%
Growth Rate
8%
Long Non-Coding RNA
8%
Daunorubicin
8%
Pharmacogenetic Testing
8%
Comprehension
8%
Genetic Architecture
8%
Myeloid
8%
Tumor Suppressor Protein
8%
Regulatory Mechanism
8%
Medicine and Dentistry
Patient
33%
Malignant Neoplasm
28%
Cells
23%
Chemotherapeutic Agent
22%
Gene
20%
Pharmacogenomics
20%
Single Nucleotide Polymorphism
19%
Drug
19%
Therapeutic Procedure
17%
Gene Expression
15%
Lymphoblastoid Cell Line
14%
Toxicity
14%
microRNA
13%
Breast Cancer
13%
Lung Cancer
12%
Platinum
12%
Capecitabine
12%
Ovarian Cancer
12%
Atlas
10%
Genetic Variability
10%
Carboplatin
9%
Combination Therapy
9%
Cancer Cell Line
9%
Cytotoxicity
8%
Phenotype
8%
Genetic Variation
7%
Analysis
7%
Neoplasm
7%
Cell Line
7%
Association
7%
Liposomal Daunorubicin
6%
Drug Response
6%
Transcriptome
6%
Somatics
6%
Development
5%
Prognosis
5%
Cisplatin
5%
Leukocyte
5%
Genome Wide Association Study
5%
Disease
5%
Drug Resistance
5%
Pharmacogenetics
5%
Pharmacology, Toxicology and Pharmaceutical Science
Drug
41%
Malignant Neoplasm
31%
Pharmacogenomics
24%
Breast Cancer
20%
Biological Marker
20%
Toxicity
13%
Cytotoxicity
13%
Platinum
13%
Cisplatin
12%
Carboplatin
11%
Chemotherapy
10%
Pharmacogenetics
9%
Drug Discovery
8%
Capecitabine
8%
Non Small Cell Lung Cancer
8%
Drug Combination
8%
Daunorubicin
7%
Anticarcinogen
6%
microRNA
6%
Neoplasm
6%
Antiinfective Agent
5%